Ultimately, mechanotransduction- and growth factor-induced gene regulation by transcriptional regulators such as YAP and BRD4 mediate fibroproliferative disease and represents a unique target for pharmacological intervention for patients with liver fibrosis. Here, BRD4 is linked to Hepatic fibrosis.